Lim Do Hyoung, Rhee Ji-Young, Park Keon Woo
1 Division of Hematology-Oncology, Department of Medicine, Dankook University Hospital, Dankook University College of Medicine, Cheonan, Republic of Korea.
2 Division of Infectious Diseases, Department of Medicine, Dankook University Hospital, Dankook University College of Medicine, Cheonan, Republic of Korea.
Int J STD AIDS. 2017 Aug;28(9):932-936. doi: 10.1177/0956462416686512. Epub 2017 Jan 17.
After the introduction of highly active antiretroviral therapy (HAART), there has been a decrease in the incidence of lymphoma among the HIV-infected population and also significantly improved survival rates. We describe a remarkable case of an HIV-infected patient with advanced stage IV diffuse large B-cell lymphoma (DLBCL), completely regressed with the use of HAART alone. He remained disease-free for 6 years and he achieved cure without chemotherapy. Although several cases of low-grade lymphoma with complete regression were reported, we could not find any case of stage IV high-grade malignant lymphoma with HAART alone in complete remission for over 5 years from our review of the literature. This unique case shows the importance of HAART in improving survival and achieving cure in HIV-high-grade malignant lymphoma.
在引入高效抗逆转录病毒疗法(HAART)之后,HIV感染人群中淋巴瘤的发病率有所下降,生存率也显著提高。我们描述了一例显著的病例,一名处于IV期晚期的HIV感染患者患有弥漫性大B细胞淋巴瘤(DLBCL),仅使用HAART就完全缓解。他保持无病状态6年,未接受化疗就实现了治愈。尽管有几例低度淋巴瘤完全缓解的病例报道,但通过对文献的回顾,我们未发现任何仅使用HAART且完全缓解超过5年的IV期高度恶性淋巴瘤病例。这一独特病例显示了HAART在提高HIV高度恶性淋巴瘤患者生存率和实现治愈方面的重要性。